Engineering TCR-T cells to target human endogenous retroviruses for non-small cell lung cancer immunotherapy
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Department of Defense
Start Date
July 1, 2025
End Date
June 30, 2028
Administered By
Pharmacology & Cancer Biology
Awarded By
Department of Defense
Start Date
July 1, 2025
End Date
June 30, 2028